Eosinophilic esophagitis (EoE) is treated with three main approaches: medication, dietary changes, or a combination of both. Most people start with either a swallowed steroid or a proton pump inhibitor (PPI), and treatment typically requires 8 to 12 weeks before a follow-up endoscopy can confirm whether it’s working. There’s no single best option for everyone, so treatment often involves some trial and adjustment.
Proton Pump Inhibitors as a Starting Point
PPIs, the same acid-reducing medications used for heartburn, are one of the simplest first steps. They work for a meaningful portion of people with EoE: about 45% achieve histologic remission, meaning the inflammation in their esophagus drops to levels considered controlled. Clinical improvement, where symptoms like difficulty swallowing get noticeably better, occurs in roughly 65% of patients.
Dose matters significantly. Double-dose PPI therapy leads to remission in about 52% of patients, compared to just 28% on a standard dose. If your doctor starts you on a higher dose and it works, a half-dose is often enough to maintain that progress long term, with about 68% of patients staying in remission on a reduced maintenance dose. PPIs are taken daily, and the response rate is similar in children and adults.
Swallowed Steroid Therapy
Topical steroids are the treatment with the strongest evidence behind them. “Topical” here means you swallow the medication so it coats your esophagus directly, rather than taking a pill that absorbs into your bloodstream. This keeps the steroid’s effects concentrated where the inflammation is, with fewer body-wide side effects than oral steroids.
The FDA-approved formulation is a budesonide oral suspension, taken as 2 mg twice daily for 12 weeks. It comes in single-dose stick packs that you swallow without mixing into food or liquid. After each dose, you need to wait at least 30 minutes before eating, drinking, or rinsing your mouth. If you do rinse, spit the water out rather than swallowing it. These steps help the medication stay in contact with your esophagus long enough to reduce inflammation.
Some people also use an off-label approach where fluticasone (from an asthma inhaler) is puffed into the mouth and swallowed rather than inhaled. This is less standardized but has been used for years when the approved suspension wasn’t available or affordable.
Elimination Diets
Because EoE is driven by an immune reaction to specific foods, removing the trigger foods can put the disease into remission without medication. The challenge is figuring out which foods are responsible, since standard allergy tests are poor predictors for EoE triggers.
The most common approach is an empiric elimination diet, where you remove a set of the most likely trigger foods all at once, then reintroduce them one at a time with endoscopies to identify the culprit. The options range from aggressive to targeted:
- Six-food elimination diet (SFED): Removes milk, wheat, eggs, soy, fish/shellfish, and tree nuts/peanuts. Histologic remission in about 61% of patients, with symptom improvement in roughly 93%.
- Four-food elimination diet (FFED): Removes milk, wheat, eggs, and soy. Remission in about 49%, symptom improvement in about 74%.
- One-food elimination (milk only): Remission in about 51%, symptom improvement in about 87%. Milk is the single most common EoE trigger, which is why removing it alone works surprisingly well.
More restrictive diets have higher remission rates but are harder to stick with and require more endoscopies during the reintroduction phase. Many gastroenterologists now start with a one or two-food elimination and escalate only if needed, since this reduces the total number of procedures and the burden on your daily life.
The Elemental Diet
An elemental diet replaces all food with an amino acid-based formula, eliminating every possible food trigger at once. It has the highest remission rate of any dietary approach, around 91%, but it’s extremely difficult to maintain. The formulas are expensive, taste poor, and remove the social and emotional dimensions of eating entirely. This option is most often used in children with severe disease or when other approaches have failed.
Biologic Therapy With Dupilumab
Dupilumab is an injectable biologic medication FDA-approved for EoE in patients aged 1 year and older who weigh at least 15 kg (about 33 pounds). It works by blocking two immune signaling molecules that drive the allergic inflammation behind EoE. For adults and older children weighing 40 kg or more, the dose is 300 mg injected weekly. Smaller children receive lower doses every other week.
This is typically reserved for people who haven’t responded to PPIs, steroids, or dietary therapy, or who can’t tolerate those options. It’s a self-administered injection, similar to medications used for eczema and asthma. The follow-up endoscopy to check response is usually done between 12 and 24 weeks after starting.
Esophageal Dilation for Narrowing
EoE can cause the esophagus to narrow over time from chronic inflammation and scarring, a process called fibrostenosis. When narrowing is severe enough to cause frequent food impactions or significant swallowing difficulty, your gastroenterologist may recommend stretching the esophagus during an endoscopy.
Dilation typically widens the esophagus from around 12 mm to about 16 mm. It treats the structural damage but not the underlying inflammation, so it’s always paired with one of the medical or dietary therapies above. Complications are uncommon. In one study of over 70 procedures, the complication rate was 7%, consisting of deep tissue tears and chest pain. No perforations occurred. Dilation is a symptom-relief procedure, not a standalone treatment.
Why Ongoing Monitoring Matters
EoE is a chronic condition, and treatment isn’t a one-and-done situation. After starting any new therapy, a follow-up endoscopy with biopsies is recommended at 8 to 12 weeks to check whether the inflammation has actually resolved. Symptoms alone are unreliable because some people feel better while still having significant eosinophil counts in their esophagus, and untreated inflammation can silently progress to scarring and narrowing.
If your initial treatment works and your disease is stable, regular clinical check-ins replace frequent endoscopies. But if treatment changes, such as stepping down to a lower steroid dose or reintroducing a food, another endoscopy is needed to confirm the adjustment didn’t trigger a relapse. Patients who go two or more years without any follow-up are at increased risk of developing the fibrostenotic complications that make the disease harder to manage later.
Practical Barriers to Treatment
Cost and complexity are real obstacles. Specialty formulas for elemental diets can run hundreds of dollars a month and may not be covered by insurance. The approved budesonide suspension is expensive without coverage, pushing some patients toward off-label alternatives. Elimination diets require significant meal planning, label reading, and repeated endoscopies, each with their own costs and time commitments. Access to a gastroenterologist experienced with EoE, and to endoscopy in general, varies widely by geography and insurance status.
Working with a dietitian who understands EoE can make elimination diets significantly more manageable and help prevent nutritional gaps, especially in children. For medications, asking your gastroenterologist about patient assistance programs or generic alternatives is worth doing early, before cost becomes a reason to skip doses or delay follow-up.